Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology

Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology

Chikungunya (CHIK) patients may be vulnerable to coronavirus disease (COVID-19). However, presently there are no anti-COVID-19/CHIK therapeutic alternatives available. The purpose of this research was to determine the pharmacological mechanism through which kaempferol functions in the treatment of C...

Full description

Bibliographic Details
Main Authors: Md Arju Hossain, Md Sohel, Tayeba Sultana, Md Imran Hasan, Md Sharif Khan, K.M. Kaderi Kibria, S.M. Hasan Mahmud, Md Habibur Rahman
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Molecular coupling
Kaempferol
Chikungunya
COVID-19
TP53
TNF
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914823001351

Internet

http://www.sciencedirect.com/science/article/pii/S2352914823001351

Similar Items